Valeant CEO makes bet on compensation package & more: 3 updates on GI companies

Here are three updates on GI companies to note from the past week.

Laval, Canada-based Valeant Pharmaceuticals CEO Joe Papa made a bet on his salary as half of his compensation package relies on Valeant's stock performance.

Valeant Pharmaceuticals' former CEO Michael Pearson is suing the company for 3 million in shares that the company allegedly withheld from his exit package.

Irving, Texas-based Miraca Life Sciences expanded its InformTx therapeutic drug monitoring program to include Simponi and patient-developed antibodies to Simponi.

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Webinars

Featured Whitepapers

Featured Podcast